Kainos Medicine Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$9.9M
- Investors
-
10
Kainos Medicine General Information
Description
Developer of novel drugs designed to advance treatments for cancer, brain, and infectious diseases. The company offers a diverse pipeline, including compounds in clinical trials for Parkinson's disease and HIV/AIDS, enabling businesses to access therapies for complex and underserved conditions.
Contact Information
Website
www.kainosmedicine.comCorporate Office
- 3rd Floor, Building. A, Korea Bio-Park
- 700 Daewangpangyo-ro, Bundang-gu
- Seongnam, Gyeonggi 13488
- South Korea
Corporate Office
- 3rd Floor, Building. A, Korea Bio-Park
- 700 Daewangpangyo-ro, Bundang-gu
- Seongnam, Gyeonggi 13488
- South Korea
Kainos Medicine Timeline
Kainos Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. PIPE | 05-Jan-2026 | $9.9M | Completed | Generating Revenue | ||
| 18. PIPE | 21-Mar-2025 | Completed | Generating Revenue | |||
| 17. PIPE | 10-Jun-2024 | Completed | Generating Revenue | |||
| 16. PIPE | 23-Jun-2022 | Completed | Generating Revenue | |||
| 15. PIPE | 11-Nov-2021 | Completed | Generating Revenue | |||
| 14. PIPE | 01-Jan-2021 | Completed | Generating Revenue | |||
| 13. PIPE | 09-Aug-2019 | Completed | Generating Revenue | |||
| 12. PIPE | 30-Aug-2018 | Completed | Generating Revenue | |||
| 11. PIPE | 16-May-2018 | $4.75M | $11.5M | Completed | Generating Revenue | |
| 10. PIPE | 22-Dec-2017 | $4.25M | $6.74M | Completed | Generating Revenue |
Kainos Medicine Patents
Kainos Medicine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026054314-A1 | Novel polynucleotide encoding faf1 protein and faf1 protein variant | Pending | 06-Sep-2024 | ||
| JP-2025533331-A | Cell line for producing faf1 exosomes at high yield and method for preparing same | Pending | 29-Sep-2022 | ||
| AU-2023350542-A1 | Cell line for producing faf1 exosomes in high yield, and preparation method therefor | Active | 29-Sep-2022 | ||
| AU-2023350542-B2 | Cell line for producing faf1 exosomes in high yield, and preparation method therefor | Active | 29-Sep-2022 | ||
| EP-4596699-A1 | Cell line for producing faf1 exosomes in high yield, and preparation method therefor | Pending | 29-Sep-2022 | C12N15/85 |
Kainos Medicine Signals
Kainos Medicine Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axis Investment | Venture Capital | Minority | ||
| Magna Investment (Seoul) | Venture Capital | Minority | ||
| DreamStone Private Equity | PE/Buyout | Minority | ||
| NH Investment & Securities | Investment Bank | Minority | ||
| Alphaview | Corporation | Minority |
Kainos Medicine Investments & Acquisitions (2)
Kainos Medicine’s most recent deal was a Early Stage VC with FAScinate Therapeutics for . The deal was made on 01-Aug-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| FAScinate Therapeutics | 01-Aug-2020 | Early Stage VC | Drug Discovery | ||
| Hana Financial Eleventh Special Purpose Acquisition | 08-Jun-2020 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Kainos Medicine FAQs
-
When was Kainos Medicine founded?
Kainos Medicine was founded in 2007.
-
Where is Kainos Medicine headquartered?
Kainos Medicine is headquartered in Seongnam, South Korea.
-
What is the size of Kainos Medicine?
Kainos Medicine has 25 total employees.
-
What industry is Kainos Medicine in?
Kainos Medicine’s primary industry is Biotechnology.
-
Is Kainos Medicine a private or public company?
Kainos Medicine is a Private company.
-
What is Kainos Medicine’s current revenue?
The current revenue for Kainos Medicine is .
-
How much funding has Kainos Medicine raised over time?
Kainos Medicine has raised $34.6M.
-
Who are Kainos Medicine’s investors?
Axis Investment, Magna Investment (Seoul), DreamStone Private Equity, NH Investment & Securities, and Alphaview are 5 of 10 investors who have invested in Kainos Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process